Search research articles
Contact Us
Filters
Showing results (141-150 of 187) with videos related to
Page
of 19
Sort By:
The Journal of Biological Chemistry
|
January 25, 1993
c-myb transactivates cdc2 expression via Myb binding sites in the 5'-flanking region of the human cdc2 gene
D H Ku, S C Wen, A Engelhard, et al.
Cancer Research
|
June 1, 1995
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis
T Skorski, M Nieborowska-Skorska, C Szczylik, et al.
Oncogene
|
February 3, 2000
Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation
G De Falco, L Bagella, P P Claudio, et al.
Cancer Research
|
April 15, 1994
Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation
G Raschella, A Romeo, A Negroni, et al.
Journal of the National Cancer Institute
|
April 3, 1996
Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice
C Leonetti, I D'Agnano, F Lozupone, et al.
British Journal of Haematology
|
June 1, 1996
Effect of basic (FGF-2) and acidic (FGF-1) fibroblast growth factors on early haemopoietic cell development
M Z Ratajczak, J Ratajczak, M Skorska, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 10, 1994
Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide
T Skorski, M Nieborowska-Skorska, N C Nicolaides, et al.
Molecular and Cellular Biology
|
July 27, 2000
BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway
D Perrotti, A Iervolino, V Cesi, et al.
Journal of the National Cancer Institute
|
February 3, 2000
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects
G Pagnan, D D Stuart, F Pastorino, et al.
Blood
|
May 16, 1998
Role of p53 in hematopoietic recovery after cytotoxic treatment
P Wlodarski, M Wasik, M Z Ratajczak, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 187) with videos related to
Sort By:
Page
of 19
The Journal of Biological Chemistry
|
January 25, 1993
c-myb transactivates cdc2 expression via Myb binding sites in the 5'-flanking region of the human cdc2 gene
D H Ku, S C Wen, A Engelhard, et al.
Cancer Research
|
June 1, 1995
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis
T Skorski, M Nieborowska-Skorska, C Szczylik, et al.
Oncogene
|
February 3, 2000
Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation
G De Falco, L Bagella, P P Claudio, et al.
Cancer Research
|
April 15, 1994
Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation
G Raschella, A Romeo, A Negroni, et al.
Journal of the National Cancer Institute
|
April 3, 1996
Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice
C Leonetti, I D'Agnano, F Lozupone, et al.
British Journal of Haematology
|
June 1, 1996
Effect of basic (FGF-2) and acidic (FGF-1) fibroblast growth factors on early haemopoietic cell development
M Z Ratajczak, J Ratajczak, M Skorska, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 10, 1994
Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide
T Skorski, M Nieborowska-Skorska, N C Nicolaides, et al.
Molecular and Cellular Biology
|
July 27, 2000
BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway
D Perrotti, A Iervolino, V Cesi, et al.
Journal of the National Cancer Institute
|
February 3, 2000
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects
G Pagnan, D D Stuart, F Pastorino, et al.
Blood
|
May 16, 1998
Role of p53 in hematopoietic recovery after cytotoxic treatment
P Wlodarski, M Wasik, M Z Ratajczak, et al.
Page
of 19